Short Stature in KBG Syndrome: First Responses to Growth Hormone Treatment
Authors:
- C.W. OckeloenCOC.W. Ockeloen
- L. SävendahlLSL. Sävendahl
- D. BeckersDBD. Beckers
- K. DevriendtKDK. Devriendt
- T. KleefstraTKT. Kleefstra
- C.E.L. CarelsCCC.E.L. Carels
- G. GrigelionieneGGG. Grigelioniene
- A. NordgrenANA. Nordgren
- I. FrancoisIFI. Francois
- F. de ZegherFZF. de Zegher
- K. CasteelsKCK. Casteels
- 1 April 2015
- journal article
- case report
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 83 (5) , 361-364
Abstract
Background: KBG syndrome is a rare disorder characterized by intellectual disability and associated with macrodontia of the upper central incisors, specific craniofacial findings, short stature and skeletal anomalies. Genetic corroboration of a clinical diagnosis has been possible since 2011, upon identification of heterozygous mutations in or a deletion of the ANKRD11 gene. Methods: We summarized the height data of 14 adults and 18 children (age range 2-16 years) with a genetically confirmed diagnosis of KBG syndrome. Two of these children were treated with growth hormones. Results: Stature below the 3rd centile or -1.88 standard deviation score (SDS) was observed in 72% of KBG children and in 57% of KBG adults. Height below -2.50 SDS was observed in 62% of KBG children and in 36% of KBG adults. The mean SDS of height in KBG children was -2.56 and in KBG adults -2.17. Two KBG children on growth hormone therapy increased their height by 0.6 and 1 SDS within 1 year, respectively. The former also received a gonadotropin-releasing hormone agonist due to medical necessity. Conclusion: Short stature is prevalent in KBG syndrome, and spontaneous catch-up growth beyond childhood appears limited. Growth hormone intervention in short KBG children is perceived as promising.Keywords
This publication has 10 references indexed in Scilit:
- Further delineation of the KBG syndrome phenotype caused by ANKRD11 aberrationsEuropean Journal of Human Genetics, 2014
- Haploinsufficiency of ANKRD11 (16q24.3) Is Not Obligatorily Associated with Cognitive Impairment but Shows a Clinical Overlap with Silver-Russell SyndromeMolecular Syndromology, 2013
- Partial deletion of ANKRD11 results in the KBG phenotype distinct from the 16q24.3 microdeletion syndromeAmerican Journal of Medical Genetics Part A, 2013
- Mutations in ANKRD11 Cause KBG Syndrome, Characterized by Intellectual Disability, Skeletal Malformations, and MacrodontiaThe American Journal of Human Genetics, 2011
- ANKRD11 gene deletion in a 17-year-old maleClinical Dysmorphology, 2011
- Haploinsufficiency of ANKRD11 causes mild cognitive impairment, short stature and minor dysmorphismsEuropean Journal of Human Genetics, 2011
- References for growth and pubertal development from birth to 21 years in Flanders, BelgiumAnnals of Human Biology, 2009
- KBG syndrome: Report of twins, neurological characteristics, and delineation of diagnostic criteriaAmerican Journal of Medical Genetics Part A, 2007
- KBG syndromeOrphanet Journal of Rare Diseases, 2006
- The KBG syndrome: Confirmation of autosomal dominant inheritance and further delineation of the phenotypeAmerican Journal of Medical Genetics Part A, 2004